Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Feb 21, 2013 · 10-K · 52 days after period end · 0001193125-13-068680
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Net Income | -$114.00K | $152.00K | — |
| EPS Diluted | $0.00 | $0.00 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Feb 21, 2013 · 52 d after period end
